FR2159421B1 - - Google Patents

Info

Publication number
FR2159421B1
FR2159421B1 FR7239745A FR7239745A FR2159421B1 FR 2159421 B1 FR2159421 B1 FR 2159421B1 FR 7239745 A FR7239745 A FR 7239745A FR 7239745 A FR7239745 A FR 7239745A FR 2159421 B1 FR2159421 B1 FR 2159421B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7239745A
Other languages
French (fr)
Other versions
FR2159421A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2155963A external-priority patent/DE2155963A1/en
Priority claimed from DE19722248791 external-priority patent/DE2248791A1/en
Priority claimed from DE19722248792 external-priority patent/DE2248792A1/en
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of FR2159421A1 publication Critical patent/FR2159421A1/fr
Application granted granted Critical
Publication of FR2159421B1 publication Critical patent/FR2159421B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
FR7239745A 1971-11-11 1972-11-09 Expired FR2159421B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2155963A DE2155963A1 (en) 1971-11-11 1971-11-11 5,7-diamino-thiazolo(5,4-d)pyrimidines - with hypotensive and antithrombotic activity
DE19722248791 DE2248791A1 (en) 1972-10-05 1972-10-05 Thiazolo (5,4-d) pyrimidines - by reaction of halothiazolo pyrimidines with amines,for treating thrombosis,hypotension
DE19722248792 DE2248792A1 (en) 1972-10-05 1972-10-05 Thiazolo (5,4-d) pyrimidines - by reaction of halothiazolo pyrimidines with amines,for treating thrombosis,hypotension

Publications (2)

Publication Number Publication Date
FR2159421A1 FR2159421A1 (en) 1973-06-22
FR2159421B1 true FR2159421B1 (en) 1976-03-05

Family

ID=27183827

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7239745A Expired FR2159421B1 (en) 1971-11-11 1972-11-09

Country Status (11)

Country Link
JP (1) JPS4885596A (en)
AU (1) AU4875672A (en)
BE (1) BE791242A (en)
DD (1) DD105450A5 (en)
FR (1) FR2159421B1 (en)
GB (1) GB1390658A (en)
HU (1) HU165855B (en)
IL (1) IL40800A0 (en)
NL (1) NL7215222A (en)
PL (1) PL79689B1 (en)
SU (1) SU493974A3 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7893059B2 (en) 2007-09-24 2011-02-22 Genentech, Inc. Thiazolopyrimidine PI3K inhibitor compounds and methods of use
ES2665277T3 (en) * 2009-03-13 2018-04-25 Katholieke Universiteit Leuven K.U. Leuven R&D Purine analogues and their use as immunosuppressive agents
SG175708A1 (en) 2009-05-27 2011-12-29 Genentech Inc Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
AU2012267556B9 (en) 2011-06-09 2017-05-11 Rhizen Pharmaceuticals Sa Novel compounds as modulators of GPR-119
GB201119401D0 (en) * 2011-11-10 2011-12-21 Ucb Pharma Sa Therapeutic agents
CN103896857B (en) * 2012-12-26 2015-12-23 上海医药工业研究院 A kind of preparation method of 4,6-bis-chloro-2-(rosickyite base) pyrimidine-5-amine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB786007A (en) * 1956-01-30 1957-11-06 Wellcome Found Thiazolo-pyrimidines

Also Published As

Publication number Publication date
SU493974A3 (en) 1975-11-28
IL40800A0 (en) 1973-01-30
HU165855B (en) 1974-11-28
NL7215222A (en) 1973-05-15
BE791242A (en) 1973-05-10
JPS4885596A (en) 1973-11-13
DD105450A5 (en) 1974-04-20
AU4875672A (en) 1974-05-16
FR2159421A1 (en) 1973-06-22
GB1390658A (en) 1975-04-16
PL79689B1 (en) 1975-06-30

Similar Documents

Publication Publication Date Title
ATA136472A (en)
AR196074A1 (en)
FR2159421B1 (en)
AU2658571A (en)
AU2691671A (en)
AU2742671A (en)
AU2684071A (en)
AU2894671A (en)
AU2485671A (en)
AU2564071A (en)
AU2486471A (en)
AU2399971A (en)
AU2669471A (en)
AU2930871A (en)
AU2654071A (en)
AU2588771A (en)
AU2577671A (en)
AU2724971A (en)
AU2503871A (en)
AU2927871A (en)
AR192311Q (en)
AU2907471A (en)
AU2885171A (en)
AU2473671A (en)
AU2456871A (en)

Legal Events

Date Code Title Description
ST Notification of lapse